Background: Experimental data from isolated rat hearts suggest that glycolysis in severe myocardial ischemia is inhibited by accumulation of glycolytic metabolites. In contrast, positron emission tomography (PET) in patients with myocardial ischemia records a 18 'mismatch' between the decreased coronary flow in viable ischemic tissue and an increased fluorodeoxyglucose ( FDG) signal. To resolve this contradiction, we investigated glucose uptake at very low coronary flows in the isolated rat heart model. Methods: Rates of glucose uptake were measured in the isolated Langendorff-perfused Wistar rat heart, at control (12-15 ml / g wet wt / min) and low coronary flows (0.1, 0.2 and 0.5 ml / g wet wt / min) and at a range of glucose concentrations (2.75, 5.5, 11 and 22 mM). Results: The steady-state rate of glucose uptake versus glucose concentration could be described by a double rectangular hyperbola at each coronary flow. Glucose uptake fell to levels significantly below control at low coronary flows. However, the extraction of glucose (glucose uptake as % of glucose delivered) rose sharply, from 1% at control coronary flows, to 25-30% at low coronary flows. Crossover analysis of glycolytic intermediates in freeze-clamped tissue indicated little inhibition at any specific site, although phosphofructokinase activity was restricted when glycolytic substrate availability was high. Insulin and preconditioning both increased glucose uptake with 11 mM glucose, possibly by increasing membrane transporter density and thus increasing glucose delivery to the cytosol. Conclusions: Despite the reduction in absolute glucose uptake at low coronary flow-rates, the extraction of glucose was greatly increased, possibly following GLUT4 translocation. Delivery of glucose to the glycolytic pathway appears to be a major controlling site of glycolysis in low-flow ischemia. Downstream regulation is then distributed along the pathway with no one site exerting greater inhibition than reduced glucose delivery.
Introduction
. The difference between the increased FDG signal and the fall in coronary flow is called 'metabolism / perfuOver 20 years ago, Neely and Rovetto reported that sion mismatch' [7] . These observations suggest that absolute rates of glucose uptake and glycolysis are reduced myocardial glucose uptake could be enhanced in ischemia, in ischemia in isolated hearts, a phenomenon attributed to and that glycolysis may not be inhibited. Other invesinhibition of the glycolytic pathway at glyceraldehyde-3-tigators have reached similar conclusions with in vivo phosphate dehydrogenase (GAPDH) [1, 2] by a build-up of models [8] , but these concepts have not been clarified in an metabolites [1, [3] [4] [5] .
isolated heart, the model in which glycolytic regulation In contrast, positron emission tomography (PET), which was initially described. 18 measures the transfer of F-labelled deoxyglucose We examined glucose uptake in the isolated perfused rat 18 18 ( FDG) into tissue in vivo, shows an increased FDG heart over a range of low coronary flows, thought to be uptake in relation to the fall in the coronary flow-rates in more comparable to in vivo ischemic coronary flow-rates viable heart muscle of patients with coronary artery disease (defined as those coronary flows found in the subendocardium of an area perfused by an artery which is then ligated, i.e., 0.07-0.15 ml / g wet wt / min in pigs and dogs with 11 mM glucose with or without insulin (1 U / l), and [8] ). The crucial issue is whether, when compared to the subjected to 30 min of global ischemia with no flow, or a reduction in coronary flow, the rate of glycolysis is low flow of 0.2 ml / g wet wt / min. Two additional groups reduced proportionately, or is upregulated relative to of hearts (n56 / group) (with or without insulin) were coronary flow, as suggested by observations including preconditioned with 5-min ischemia and 5-min reperfusion 'mismatch'. We also investigated the effect of insulin and prior to low-flow ischemia. Glucose uptake and lactate preconditioning on glucose uptake and utilisation within washout were measured during low flow ischemia. the cell, both being factors which may increase translocaHearts were clamped at the onset, after 15-min and after tion of GLUT4 glucose transporters to the membrane 30-min ischemia in the glucose and glucose1insulin [9, 10] .
groups with Wollenberger tongs kept in liquid nitrogen, for analysis of tissue metabolites. 6 hearts were used for each time point. Crossover analysis of the glycolytic inter-2. Methods mediates was then performed.
2.1. Isolated rat heart perfusions 2.1.3. Biochemistry Glucose uptake was assessed by the rate of conversion 2.1.1. Experimental apparatus of glucose 6-phosphate to fructose 6-phosphate, measured 3 3 Male Wistar rats (263618 g) fed ad libitum (mean fresh by the rate of H O production from D[2-H] glucose [1, 3] . 2 3 heart weight 1.0560.01 g) were anaesthetised with ether, A trace amount (0.087 mM; 0.2 mCi / l) of D [2- H] glucose following which 200 i.u. heparin was injected into the (Amersham, Amersham, Bucks, UK) was added to the 3 3 exposed femoral vein. 1.36, Na-acetate 5) and gassed with 95% O 5% CO to with ethanol and NaOH for analysis of glycogen content 2 2 maintain pH at 7.4. Glucose was added to all perfusates in [14] . The extracts were then assayed using spectrophotoconcentrations as described below. Five millimolar acetate metric assays adapted for use on a Cobas Fara centrifugal was present as an alternate substrate in all perfusions such analyser (Roche Diagnostics, Berne, Switzerland) [13] . that when glucose was present only at very low conValues were expressed as mmol / g wet wt. Glycogen was centrations, adverse effects associated with limited subexpressed as mmol 6-carbon units / g wet wt, after assaying strate perfusion [11, 12] were reduced. In addition, acetate the extract for glucose. is a fatty acid analogue, the major substrate used by the heart. Acetate may influence glucose utilisation in normox-2.2. Expression of results and curve fitting ia. However, our values were similar to those obtained in the absence of acetate, especially in low coronary flow Results were expressed as mean6SEM. All data were conditions (data not shown).
expressed as per gram wet weight (wet weight553dry weight from previous determinations). The data were fitted 2.1.2. Experimental protocol using Origin (MicroCal, Northampton, MA) computer A dose-response to glucose was obtained at a range of programme. coronary flows. Hearts perfused with one of four different glucose concentrations (2.75, 5.5, 11 and 22 mM) were subjected to 15 min aerobic perfusion, followed by 30 min 3. Results global ischemia with low coronary flows of 0.1, 0.2 or 0.5 ml / g wet wt / min (n56 / group). An infusion pump was 3.1. Glucose uptake at different coronary flows and used to deliver oxygenated buffer during low-flow isglucose concentrations chemia. The temperature was maintained at 378C by water jacketing, and monitored by a thermistor probe in the right 3.1.1. Changes in glucose uptake in control and ischemic ventricle. Coronary efluents were collected for 15 s after hearts 15 min perfusion, and over each 5-min period during Preischemic glucose uptake rates were dependent on the ischemia. Two hundred microlitre samples were taken for perfusate glucose concentration, as shown in Figs. 1 and 2. assessment of glucose uptake.
At each low coronary flow, glucose uptake fell sharply In a second series of experiments, hearts were perfused from control levels, and then increased to peak at 15-20 min ischemia (see Fig. 1 ). With 2.75 mM glucose, glucose uptake declined after 15 min ischemia at each low coronary flow, such that by 30 min ischemia, the rates of glucose uptake were similar regardless of coronary flow (cf. Fig. 1a , b, c). With higher glucose concentrations, glucose uptake was maintained at a plateau level throughout ischemia at each coronary flow rate (Fig. 1) . With a coronary flow of 0.5 ml / g wet wt / min, rates of glucose uptake with 11 and 22 mM glucose were similar to those in preischemic hearts (Fig. 1c) .
Steady-state glucose uptake-effect of concentration and coronary flow
The steady state glucose uptake per min, taken as the uptake at 15-min ischemia, was plotted against glucose concentration for each coronary flow. Double rectangular hyperbolic relationships were obtained (Fig. 2) , equivalent to Michaelis-Menten kinetics, such that glucose uptake increased linearly from 0-5 mM, and plateaued at concentrations greater than 11 mM. Similar trends were observed at coronary flows of 0.2 and 0.5 ml / g wet flows ( Fig. 2) suggests that, in ischemia, a higher mini-mum glucose concentration, of at least 11 mM glucose, is delivery (mmol / min / g wet wt) required to sustain glucose uptake than is necessary in 5 glucose concentration (mmol / ml) normoxia. The increased transit time of the perfusate 3 coronary flow (ml / g wet wt / min) (1) through the coronary vasculature with a reduced coronary flow may lead to early extraction of the available glucose, (glucose concentration of the perfusate), the term perin the initial portion of the perfused tissue. The concentage glucose extraction was derived, centration gradient across the cell membrane at the termi%Glucose extraction nal portion of the vasculature with the lower glucose 5 [glucose uptake(mmol / min / g wet wt) / delivery concentrations would then be insufficient to sustain facilitated diffusion. This is in agreement with standard con-(mmol / min / g wet wt)] 3 100 (2) cepts of membrane transport kinetics.
When percentage extraction of each data point in Fig. 3a An additional explanation for the difference in glucose was plotted against coronary flow, a negative doubleuptake observed at low flows and low glucose concenexponential relationship was found (shown in Fig. 3b ), trations is inhomogeneity of flow in the tissue. Some described by: portions of the hearts will be subjected to a much higher (2x / 31.78) (2x / 0. 38) flow than others, especially as ischemia progresses. The %extraction 5 6.81 e 1 14.91 e (3) steepness of the perfusion gradient will vary depending on 2 with x5coronary flow (ml / g wet wt / min) and x 514.91. the residual flow rate, the glucose concentration and At the 'normal' range of coronary flows for an isolated glucose uptake (determinants of viability and thus of vessel perfused heart (12-16 ml / g wet wt / min), % extraction compliance), but may result in the same mean glucose was very low, less than 3% of that delivered to the uptake as a heart with a lesser gradient. However, within myocardium, even though glucose was the main external limits, we believe that we can draw certain conclusions substrate. There was a sharp increase in glucose uptake at from the data. This issue is discussed further in Section coronary flows less than about 1 ml / g wet wt / min, from 4.6.
less than 3% up to 25-28% at very low flows. Rates of glucose uptake neared saturation at glucose When the percentages of glucose extraction for the concentrations greater than 11 mM. Only an increase in different glucose concentrations (from Fig. 2 ) were plotted coronary flow could increase absolute glucose uptake at against delivery of glucose (coronary flow3concentration) high glucose concentrations. Thus the maximum rate of rather than coronary flow, to allow for comparison of the glucose uptake (apparent V ) was dependent on coronary max data, a similar negative exponential relationship was found flow (Fig. 2 ). This finding can be explained by improved ( Fig. 3c) , with a sharp increase in glucose extraction at metabolism within the cell and thus increased glucose reduced glucose delivery. The pattern is the same for the demand, as well as increased delivery.
full range of glucose concentrations. 3.2. Glucose uptake at a glucose concentration of 11 mM 3.3. The effects of insulin and preconditioning on glucose uptake and lactate washout 3.
Absolute rates of glucose uptake
The standard concentration of glucose used in isolated Data from hearts subjected to 30-min low flow ischemia rat heart perfusions in the absence of insulin is 11 mM.
(0.2 ml / g wet wt / min) with 11 mM glucose were comThis concentration is twice the physiological concentration pared to baseline values with zero flow ischemia, in the of glucose in plasma and ensures adequate glucose uptake presence or absence of insulin (1 U / l Fig. 4a ). Lactate production was tation, with modulation by oxygen consumption, work rate, increased in insulin-treated hearts ( Fig. 4b ), although lesser insulin and alternate substrate availability. Glucose uptake tissue accumulation was found in the low flow hearts is not determined by coronary flow under these conditions. because of washout (Table 1) . Total lactate production At low coronary flows, the dependence of glucose uptake (tissue level1washout) was unchanged in low flow vs zero on coronary flow increased (Fig. 3a) , with a fall in glucose flow hearts (26.65 mmol vs 27.04 mmol). uptake.
Preconditioned hearts showed an increased glucose Absolute glucose uptake is frequently reported in the uptake compared to control hearts with only 11 mM literature. However, the uptake of glucose relative to its glucose ( Fig. 4a) . However, in the presence of insulin, availability to the tissue has not been established for preconditioning had no additional effect (Fig. 4a ). Preisolated rat hearts. In order to establish the relationship conditioned hearts had a lower lactate production ( Fig. 4b ) between glucose uptake and delivery of glucose, where:
because of reduced preischemic glycogen content [15] . 
3.4.
Tissue metabolites maintained residual coronary flow, the fall in glycolytic intermediates was not observed. Glycolysis was mainTissue levels of glycolytic intermediates, glycogen and tained at a steady state throughout the 30 min ischemic high-energy phosphates, are shown in Table 1 . Insulinperiod, as suggested both by glucose uptake and metabolite enhanced glucose uptake and glycogen content, thereby accumulation. limiting the effect of reduced substrate delivery on gly-
The glycolytic intermediates downstream from glucose colytic flux rates in ischemia and allowing regulatory sites can be broadly grouped into intermediates (G6P, F6P, FDP, further downstream to be indicated.
GAP, DHAP, pyruvate) and end-products (L-alanine, aGlycogen is an important contributor to glycolytic flux.
glycerophosphate, lactate). The percentage of intermediates The majority of glycogen is broken down in the initial to intermediates1products declined during ischemia, as minutes of ischemia (12.4 mmol / g wet wt in the first 15 the product accumulation greatly outweighed that of the min of glucose zero flow), and does not really contribute to intermediates (Table 1 ). In addition, with a residual low glycolytic flux after this time (2.5 mmol / g wet wt utilised coronary flow, a large amount of the products, especially in last 15 min). The small amount of residual glycogen lactate, will be washed out, further reducing the relative may well be proglycogen, which is more resistant to intermediate accumulation. Thus, product formation greatbreakdown [16] , and is not indicative of glycolytic inhibily outweighs any intermediate accumulation, and negates tion in ischemia, as has been suggested [17] . The rate of significant inhibition at any point along the pathway. glycogen breakdown was attenuated with low-flow isaGP levels increased significantly during ischemia, chemia (61% vs. 91% over 30 min), especially in the indicative of a redirection of DHAP to aGP, instead of to presence of insulin (44%).
GAP and eventually lactate. However, the amount of aGP Analysis of intermediate accumulation by the crossover was significantly less than that of lactate. While this theorem [1, 18] highlighted the accumulation of G6P, F6P redirection may indicate some inhibition at GAPDH, the 1 and the end products, lactate and a-glycerophosphate (Fig.  aGP shuttle is important in restoring NAD levels, as is 5). Contrary to previous authors, who reported increases of the reduction of pyruvate to lactate. An accumulation of 700% and 300% in DHAP and GAP respectively [1] , we aGP and restoration of the redox potential may thus be a found no significant accumulation of these glycolytic protective mechanism, although this is still to be conintermediates. DHAP levels in our hearts in fact decreased firmed. significantly during the more severe ischemia used in the In the presence of insulin, G6P and F6P levels increased present study (Table 1) . Levels of intermediates tended to greatly during ischemia (Table 1 , Fig. 5 ), as a result of be higher at 15 min than at 30 min in zero-flow ischemia increased glycogen and glucose uptake. Levels of FDP, (Table 1 ; Fig. 5 ), indicating that glycolysis was more GAP and DHAP were lower after 30 min compared to the limited after 30 min, with all available intermediates used 15-min values in insulin hearts, despite high G6P and F6P up to provide ATP in the absence of substrate. With a values, possibly indicating some enzyme inhibition (at Fig. 4 . Effect of preconditioning and insulin on glucose uptake (a) and lactate washout (b) in hearts exposed to 30 min low-flow ischemia (0.2 ml / g wet wt / min). Hearts were perfused for 30 min prior to ischemia to allow time for glycogen accumulation and the preconditioning protocol. Preconditioned hearts were perfused for 20 min, followed by 5-min total global ischemia, and 5-min reperfusion prior to sustained ischemia. Both insulin and preconditioning increased glucose uptake, but only insulin had an effect on lactate washout. Preconditioning reduces preischemic glycogen, thereby limiting lactate washout despite increased glucose uptake. Insulin had no effect on glucose uptake in preconditioned hearts. Lactate is expressed as mmol 6-carbon units (C6) / g wet wt / min, to equate to glucose used. * p , 0.05 all groups vs glucose control.
PFK) with excess glycolytic substrate in the presence of was greater in insulin hearts, showing more redirection insulin. A 'bottle-neck' effect was seen, which was less when substrate was increased. significant with a residual flow as G6P and F6P were lower with attenuated glycogenolysis in the presence of glucose, 1 and metabolites which could inhibit PFK (i.e. lactate, H ) 4. Discussion would be washed out. Lactate accumulation was, however, significantly higher by the end of ischemia in insulin
We observed that the extraction of glucose from the hearts, despite any constriction. The percentage interperfusate is consistently increased as the coronary flow is mediate to total metabolites was higher in all insulin vs.
reduced, even to very low values. We found an increased noninsulin hearts, although there was still little evidence of removal of glucose from the perfusate, even though the significant GAPDH inhibition. aGP tissue accumulation absolute glucose uptake was decreased in severe ischemia.
glucose detritiation. This is a gross oversimplification, but within the limitations of the technique, we feel that this assumption is justified (see Section 4.6). Because accumulation of glycolytic intermediates was small compared to rates of substrate flux through glycolysis, assessed through end-product accumulation (Table  1) , we made the assumption that the glucose uptake 3 measured by D[2-H]-glucose detritiation approximates glycolytic flux. This approximation also relies on the assumption that all glucose taken up is phosphorylated (see Section 4.6). Thus, for the purposes of the present discussion, glucose entering the cell and subsequently phosphorylated was assumed to be largely converted to pyruvate, and then to lactate under anaerobic conditions. Any possible intracellular accumulation of glucose is unlikely ing the rate of the initial steps of glucose utilisation. In
The absolute values are shown in Table 1 . Hearts were clamped at the addition, in ischemia any glucose in the cell is likely to be onset, after 15 min and after 30 min zero or low flow (0.2 ml / g wet used up rapidly, as the requirement for ATP increases, and wt / min) ischemia. The dotted line represents control values (100%). See Table 1 for abbreviations.
glycogen synthesis is unlikely. Glycogenolysis contributes substrate to the glycolytic pathway, the extent of which was estimated from gross glycogen content in the hearts This increased removal relative to the fall in coronary flow prior to and at the end of ischemia. Previous calculations, 18 supports the observations of 'mismatch' with FDG in using data from hearts perfused with a coronary flow of 0.2 PET studies on dogs [19] and humans [6, 7, 20] , and ml / g wet wt / min, and 11 mM glucose [12] , show that observations of increased glucose extraction in vivo using glucose uptake and glycogen utilisation can account for all different techniques [8] .
the lactate produced, which conversely implies that all the Our results also suggest that the rate of glycolysis in glucose taken up in these conditions is converted to lactate ischemia is determined not so much by the extent of [12] . Residual oxygenation can oxidise only about 3-4% enzyme inhibition, but rather by the rate of glucose of glycolytic substrate under these conditions [12] . delivery and subsequent transport into the cell, as previously predicted by a computer model [21] . Our results are 4.2. Control vs. regulation of glycolysis in agreement with standard concepts of substrate-product relationships determining flux through a pathway [22] . We
The above assumptions invoke the concept of glycolysis do not exclude concomitant enzyme inhibition, and hence as a 'metabolon', or single unit made up of closely some inhibition of ischemic glycolysis occurs as previousassociated multiple enzymes [25] , which allows efficient ly emphasised, but any such inhibition appears of lesser 'channelling' of the product of one reaction to the next, importance than does limitation of glucose delivery by where it becomes the substrate [26] . Thus glycolysis can very low coronary flows (Fig. 6) . Thus, control of glybe seen conceptually as a 'funnel', the efflux from which, colysis in this model is related largely to substrate supply, is controlled largely by the amount of glucose which is although there may be downstream regulation at sites 'poured' into it. The amount of substrate entering the distributed along the glycolytic pathway [23] .
pathway can largely be accounted for by the amount that eventually leaves [12] (see Fig. 6 ). Enzyme inhibition can 4.1. Substrate supply, glucose uptake and glycolysis be pictured as constrictions on the funnel spout, leading to some accumulation of 'fluid' in the funnel, but these are When glucose transport is greatly stimulated, phosnot sufficient to prevent the final outflow. Thus there is phorylation of glucose by hexokinase, an important regsome regulation of flux by enzyme inhibition distributed ulator of glycolysis when intracellular glucose is in excess, along the pathway, but these individual points do not may become rate-limiting for glycolytic flux [23, 24] .
appear to be significantly rate-limiting. While PFK may However, we measured the rate of glucose utilisation have been inhibited when substrate delivery was in excess, downstream of hexokinase. For the purposes of the followeven when PFK was maximally inhibited (insulin and ing discussion, 'substrate supply' (conceptually a major low-flow ischemia) the overall rate of glycolysis was still rate-determining step in enzyme reactions [22] ) implies very high (estimated by lactate accumulation). These delivery of substrate via the coronary vasculature, transfer concepts rely on the distinction between control and into the myocyte, and the initial phosphorylation step, as regulation of a pathway, where control is defined as a (1) Glucose delivery is decreased in ischemia as the coronary flow falls, resulting in reduced absolute glucose uptake. A reduction in coronary flow below 1-2 ml / g wet wt / min appears to stimulate glucose transport, resulting in increased extraction of glucose from that delivered to the cells. Glucose uptake and phosphorylation are major controlling steps of glycolysis, even when these factors are significantly reduced as in ischemia. (2) Glycogen is rapidly depleted during ischemia (most is utilised within the first 15 min, Table 1 ). With total global ischemia, or when glucose is present only at very low concentrations, glycogen is the only significant glycolytic substrate, and the tissue content at the onset of ischemia determines subsequent glycolytic rates. (3) Phosphofructokinase (PFK) is thought to be the major site of glycolytic inhibition under normal conditions when ATP and CP levels are sufficient. Citrate and acidic pHi are the major inhibitors of the enzyme [31, 32] . When ATP and CP levels are depleted, inhibition of PFK is removed allowing glycolysis to continue. Glycolysis is stimulated at this step by fructose 2,6-bisphosphate [41] . However, recent isolated myocyte work and metabolic control analysis shows that in normoxia with sufficient substrate (glucose and insulin), glucose uptake and phosphorylation are the main rate-determining factors of glycolytic flux [23, 24] , rather than PFK. In ischemia, the site of glycolytic regulation was thought to be GAPDH rather than PFK [1] . However, if high glucose and insulin are present, regulation of glycolysis at the level of PFK, possibly due to the drop in pHi [31, 32] may become of greater importance. A large accumulation of G6P and F6P was found in ischemia, especially in insulin hearts (see Table 1 Fig . 5 ), suggesting that with sufficient or excess substrate, some feedback is present to prevent too excessive an accumulation of end product. (4) GAPDH catalyses the conversion of GAP to 2,3-bisphosphoglycerate, with the reduction of NAD to NADH 1 H . In ischemia, as lactate accumulates because of increased production and reduced washout, balancing the lactate dehydrogenase equilibrium should theoretically lead to an accumulation of 1 NADH and H . Both NADH and lactate are then thought to inhibit glycolysis at GAPDH [1, 2] . However, the importance of this mechanism in the overall regulation of glycolysis in ischemia is challenged by the findings that: (1) glycolysis in ischemia is limited by supply of substrate, in accordance with normal substrate-product relationships [22] (Fig. 2) ; (2) at low coronary flows, glucose extraction is increased (Fig. 3b) ; (3) hypoxia, associated with greatly increased glycolysis, is also associated with a high cytosolic NADH content; (4) regulation of glycolysis in control conditions with excess substrate is limited to less than 25% at all steps below phosphoglucoisomerase [23] ; and (5) crossover analysis of glycolytic intermediates does not point to inhibition at the level of GAPDH (Table 1 Fig . 5 ). In addition, with high glucose at low coronary flows, lactate washout remains at a steady state for an extended period, without any evidence of attenuation of glycolysis by feedback inhibition [12] . Tissue lactate levels were also increased if insulin was present (Table 1) . While the role of lactate-mediated inhibition of glycolysis cannot be excluded, its importance appears relatively small. Only if excess external lactate is added [40] , may GAPDH inhibition significantly attenuate the rate of glycolysis, although this mechanism has not been shown directly. The process illustrated in the figure can be regarded as a 'funnel'. Hypothetically, in ischemia, if glucose is taken into a cell and phosphorylated, its eventual fate must be lactate if the cell is still viable. Some constriction may be present to slow down the rate, but this does not affect the eventual outcome.
overall flux (e.g. workload, hormones, substrate concenpoint (e.g enzyme activity, cofactors etc) [27] . Our results tration, coronary flow etc.) while regulation occurs at call for metabolic control analysis to determine the sites of points within the pathway which modulate the flux at that regulation of glycolysis in ischemia, as has been performed on glycolysis in normoxic hearts perfused with different and DHAP during ischemia, suggesting that any inhibition substrates [23] .
at the level of GAPDH did not have a major limiting effect on flux through glycolysis [1, [3] [4] [5] (see Fig. 6 ). Evidence 4.3. Glucose uptake and extraction versus coronary flow of some inhibition at PFK [31] could be found, especially in the isolated rat heart when the substrate supply was greatly increased by the addition of insulin (Table 1) . In these conditions, the drop Glucose uptake and extraction relative to acute changes in pH may be greater from increased glycogen breakdown in coronary flow were investigated using 11 mM glucose [12] , such that acidotic inhibition of PFK is also greater (with no insulin), as is used in the majority of isolated rat [32] . However, this inhibition did not significantly limit the heart perfusions. Coronary flow, oxygen consumption and overall rate of glycolytic flux. The metabolic response of contractile function are tightly coupled, to regulate heart the tissue to excess substrate adds to the concept of function, and determine viability. At 'normal' coronary glycolysis as a 'funnel' (Fig. 6) ; at some point the amount flows in the isolated rat heart (12-16 ml / g wet wt / min), of substrate entering the pathway may transiently exceed glucose uptake is also modified, by the perfusion model that which can exit. However, eventually output will be used, the heart and work rates, coronary perfusion presincreased because of a greater accumulated input. Delivery sure, oxygen availability, alternate substrates and metabolof glucose (or availability of glycolytic substrate) and ic status of the heart (diabetic, hypertrophied, starved) enzyme inhibition thus compete to determine the final rate [11, 28] . Rates of glucose uptake are therefore not closely of glucose uptake and subsequent utilisation. dependent on coronary flow at 'control' coronary flows. However, despite variations in absolute glucose uptake 4.4. Does this relationship occur in vivo? with different models, the percentage extraction of available glucose is very low at these flows (Fig. 3b) . At the In ischemia following coronary artery ligation, coronary moderate reductions in coronary flows used by other flows in the subendocardium in large animals are usually authors (20-60% of normal coronary flows with crysin the range of 0.07-0.15 ml / g wet wt / min [8] i.e., about talloid perfusions), mean glucose uptake values may also 3-8% of normal coronary flows (1-2 ml / g wet wt / min) vary, but tend to be higher than those at higher flows [1, 4] . [8] . Thus the coronary flows used in the present study This increase can be attributed to reversal of the Pasteur (0.1-0.5 ml / g wet wt / min, about 2-8% of normal in vivo effect, with a relative hypoxia, and a fall in citrate and coronary flows in the rat-5-6 ml / g wet wt / min [33]) are ATP levels.
more 'physiological' than flows of 0.6 ml / g wet wt / min Glucose uptake, and glycolytic ATP production, is an and higher as used in previous rat heart studies [1, [3] [4] [5] . In important determinant of viability, especially when the the pig heart in vivo, there is no change in absolute glucose heart is compromised by a reduced flow [11, 12, 29] . The uptake as the coronary flow falls to 0.07-0.1 ml / g wet fate of glucose changes at a lower flow (6 ml / min vs 14 wt / min but the same negative logarithmic relationship ml / min [30] , as the ratio of anaerobic to aerobic glucose between glucose extraction and coronary flow exists [8] as utilisation increases with reduced oxygen availability [30] .
found in the rat heart. A similar increase in extraction With more severe reductions in coronary flow, as used in relative to coronary flow occurs in the dog heart with our study, mechanical function is severely curtailed, or low-flow ischemia induced by LAD ligation [34] . Thus in absent, with evidence of ischemic injury [12] . At these the rat, pig [8] , dog [10] and human heart [7] , glucose coronary flows, anaerobic glycolysis is the primary source extraction is increased with impaired coronary flow. of ATP [11] . Previously, glycolysis was thought to be inhibited in severe ischemia because glucose utilisation in 4.5. Possible mechanism of increased glucose extraction an isolated rat heart at a coronary flow of 0.6 ml / g wet wt / min was less than that in the normally perfused A component of delivery of glucose is the ability of the myocardium [4] . However, as coronary flow decreases membrane to transport glucose, which is determined by the below about 1 ml / g wet wt / min in our model ('isnumber of glucose transporters in the membrane. Insulin chemia'), the percentage extraction rises sharply (Fig. 3b) , significantly enhances glucose uptake by increasing the suggesting that the capacity of tissue to take up glucose is density of GLUT4 glucose transporters in the membrane, enhanced. Further, glycolytic flux appears to be limited and can thus increase delivery of substrate to the cytosol. largely by the availability of glucose. A similar prediction Insulin shifts the glucose uptake versus glucose concenwas made with computer modelling at low coronary flows tration curve significantly upwards (increased apparent [21] i.e. that reduced glucose uptake (and glycolysis) V ), indicating that membrane transport becomes ratemax results primarily from reduced delivery of substrate [21] . limiting when sufficient substrate is available, supporting We have confirmed these findings with ultra-low coronary the concept that the initial steps of the glycolytic path are flows and a range of glucose concentrations in an isolated of major importance in the regulation of glycolysis. The heart. mechanism of increased glucose extraction in acute isWe did not find evidence of major accumulation of GAP chemia may also be increased porosity of the sarcolemma mediated by translocation of glucose transporters (GLUT 1 as follows. Only about 5% of glucose taken up is incorpoor GLUT 4) to the membrane, shown to be triggered by rated into glycogen in the normally beating heart in the ischemia [9, 10] . Insulin can also further increase glucose absence of insulin [39] , but this value is presumably even uptake in ischemia, as we have shown, overcoming the lower in the ischemic heart where ATP formation is limitation of glucose transporter density in the membrane required, rather than energy storage. An accumulation of as a determinant of glucose delivery. In the absence of intermediates may lead to a disparity between values for insulin, only 25-30% of available glucose is taken up, glucose uptake and glycolytic flux (lactate production). leaving a large 'reserve' of glucose. Insulin increases this However, the sum of glycolytic intermediates, other than extraction to about 60-70% leaving a small 'reserve', at the products of lactate, aGP and L-alanine, does not which point the gradient of glucose across the membrane account for more than 7.5% of the total metabolite limits uptake (K of GLUT455 mM [35] ). Preconditionaccumulation, a value which decreases during ischemia m ing has also been shown to induce translocation of GLUT4 (see Table 1 , and from [1] ). While aGP accumulates to to the membrane, thereby increasing membrane affinity for quite a large extent, the values are still small compared to glucose. We found increased glucose uptake in preconboth total glycolytic substrate, and overall lactate proditioned hearts subjected to low-flow ischemia. The lack of duction. Thus these factors do not significantly affect the 3 effect of insulin in these hearts suggests a similar mechacomparison of glucose uptake measured by D[2-H]-glunism of action on GLUT4 translocation to the membrane.
cose with glycolytic flux. However, glucose uptake is not necessarily related to the 4. An important reservation of our model is that at very increased recovery of function in preconditioned hearts low coronary flows, the distribution of coronary flow in the [36] .
rat heart is likely to be heterogeneous, with consequently Membrane transporter activity may also be upregulated differing degrees of cell metabolism and viability. Howby factors associated with ischemia including formation of ever, a similar restriction could apply to the studies in the 21 adenosine [37] , increased cytosolic Ca [38] or tissue previous studies of low flow ischemia in the rat heart cyclic AMP [38] . In addition, contraction-mediated glu- [1, [3] [4] [5] 11, 12, 29, 30, 40] and investigations in the human. cose transport differs from insulin-mediated transport, PET takes an average measurement over a volume of indicating the involvement of different pathways in the tissue, which is similar to glucose extraction by the whole recruitment of glucose transporters. Further work is reisolated rat heart exposed to global decreases in coronary quired to confirm these hypotheses. Chronic adaptation to flow. However, despite the lack of cellular homogeneity in ischemia may also involve changes in GLUT expression the response of the isolated rat heart to ischemia, the and distribution.
finding of an increased glucose extraction is supported by large animal data [8, 10, 19] , and we believe this to be an 4.6. Reservations important observation. 3 1. We measured the amount of D[2-H]-glucose detritiated in the phosphoglucoisomerase reaction (G6P to 5. Summary F6P), equated to glucose uptake. These data do not differ significantly from measurements of arteriovenous glucose
The rate of delivery of substrate is a major determinant differences (data not shown), although the radioactive of absolute glucose uptake at very low coronary flows. 3 methods are more precise. D[2-H]-glucose detritiation is While absolute glucose uptake remains the same (in vivo), regarded as the 'gold standard' for measuring glucose or falls as the coronary flow falls, the percentage extraction uptake, and has also been used to reflect glycolytic flux increases greatly, indicating an ability of the myocardium 3 rates [11, 12] . Although use of D [5- H] glucose may be a to upregulate its capacity to transport glucose and thereby more accurate measure of glycolysis because it is detriprovide ATP essential for maintained cell function. Similar tiated further down the glycolytic pathway, at enolase, we conclusions have been reached by others using different found no difference between results from the two isotopes methods of analysis [8, 21, 29] . A low coronary flow (,1 in low-flow ischemia (data not shown). This result also ml / g wet wt / min in the rat heart ,10% of normal) thus implies that the majority of glucose taken up in ischemia is appears to trigger an adaptive response in the myocardium, converted to pyruvate.
possibly involving translocation of glucose transporters to 3 2. D[2-H]-glucose detritiation does not distinguish the membrane. between rates of glucose transport across the sarcolemma and subsequent phosphorylation. Rates of phosphorylation may be affected by ATP availability, which is decreased in
